A detailed history of Continuum Advisory, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Continuum Advisory, LLC holds 18 shares of UTHR stock, worth $6,495. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Previous 5 260.0%
Holding current value
$6,495
Previous $1,000 500.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$311.04 - $363.55 $4,043 - $4,726
13 Added 260.0%
18 $6,000
Q2 2024

Jul 19, 2024

SELL
$228.26 - $319.04 $684 - $957
-3 Reduced 37.5%
5 $1,000
Q1 2024

May 10, 2024

BUY
$210.76 - $249.51 $1,686 - $1,996
8 New
8 $1,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Continuum Advisory, LLC Portfolio

Follow Continuum Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.